Clinical Trials Directory

Trials / Unknown

UnknownNCT03895866

Persistent Cervical HPV Infection With Clearance and Vaginal Microbiota

Clinical Study on the Relationship Between Persistent Cervical HPV Infection With Clearance and Vaginal Microbial Community

Status
Unknown
Phase
Study type
Observational
Enrollment
240 (estimated)
Sponsor
Peking Union Medical College Hospital · Academic / Other
Sex
Female
Age
20 Years – 45 Years
Healthy volunteers
Accepted

Summary

Since other genital infections enhance HIV susceptibility by inducing inflammation, the investigators study the relationship between the vaginal microbiota composition and the persistence infection and clearance of HPV infection.

Detailed description

Persistent infection with oncogenic Human Papillomavirus (HPV) is necessary but not sufficient for the development of cervical cancer. Additional factors correlated with HPV persistence include immunodeficiency caused by HIV, smoking, use of oral contraceptives and, more recently reported, vaginal dysbiosis. In a state of dysbiosis, there is a marked reduction of Lactobacillus and a high diversity of bacteria, with increased abundance of anaerobic bacterial species. High-risk HPV cervical infections are common in young, sexually active women. Most of these infections are transient and do not cause clinical symptoms. After 12-30 months of HPV infection, 70-90% of patients can be cleared naturally, but there are still a small number of patients with high-risk HPV infection can not be eliminated by itself and continue to infect, and can develop into cervical intraepithelial neoplasia, eventually progressing to invasive cervical cancer. Persistent infection of high-risk HPV is a necessary condition for the occurrence of cervical cancer and precancerous lesions. Early blocking of persistent infection of high-risk HPV and timely treatment of cervical precancerous lesions are of great significance in preventing the occurrence of cervical cancer. This project intends to study the relationship between vaginal microbial composition and persistent HPV infection, and determine the related strains and their molecular mechanisms, so as to provide new ideas and basis for its treatment.

Conditions

Interventions

TypeNameDescription
OTHERThe participants were assigned to different groups according to the results of HPV detection.The participants were assigned to different groups according to the results of HPV detection

Timeline

Start date
2019-04-11
Primary completion
2020-02-11
Completion
2020-02-11
First posted
2019-03-29
Last updated
2019-08-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03895866. Inclusion in this directory is not an endorsement.